Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Schering-Plough claims felbamate metabolite

April 5, 1996

Roche Bioscience claims antiemetic drugs

April 5, 1996

Anticonvulsants claimed by Bristol-Myers Squibb

April 5, 1996

Synthelabo reports antidepressants

April 5, 1996

5-HT1A/5-HT2C receptor ligands from Roche

April 5, 1996

New antipsychotic drugs from HMR

April 5, 1996

Meiji claims improved antipsychotic agents

April 5, 1996

Warner-Lambert discloses ACAT inhibitors

April 5, 1996

BMS claims beta3 agonists in patent literature

April 5, 1996

ACAT inhibitors claimed by DuPont Merck

April 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 21, 2025
Lost in trans-lation? Trump’s mouse charge doesn’t click
BioWorld
U.S. President Donald Trump touched off a not-uncommon flurry of puzzlement and outrage when, during his speech to Congress on March 4, he referred to an example...
Clinical trial fraud ends with guilty pleas
BioWorld
In another real-life episode of “sponsor beware,” the owners of a clinical research facility pleaded guilty March 10 in U.S. district court to fraud charges...
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...